Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|July 1, 1985
Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failureH D White, J P Ribeiro, L H Hartley, et al.
Circulation|January 28, 1998
Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsivenessJ M Hare, M M Givertz, M A Creager, et al.
Circulation Research|May 26, 2001
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontinN A Trueblood, Z Xie, C Communal, et al.
The Journal of Clinical Investigation|March 21, 1998
Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblastsA Calderone, C M Thaik, N Takahashi, et al.
Journal of Cardiac Failure|June 23, 2001
A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failureE Loh, U Elkayam, R Cody, et al.
Circulation Research|October 1, 1992
Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cellsL Sen, R A Bialecki, E Smith, et al.
Circulation|November 1, 1995
Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAsA Calderone, N Takahashi, N J Izzo, et al.
Circulation|December 1, 1994
Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunctionE Loh, J S Stamler, J M Hare, et al.
Circulation|March 1, 1986
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsivenessW S Colucci, R F Wright, B E Jaski, et al.
The American Journal of Cardiology|January 1, 1993
No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failureT A Schmidt, P D Allen, W S Colucci, et al.
Pageof 17